SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and service provider of aesthetic clinics, has been added as a member of the Russell 3000 ® Broad Market Index , effective after the U.S. market opens on June 30, as part of the Russell 2025 Index reconstitution.
Inclusion in the Russell 3000 ® Index , which remains in effect for one year, means automatic inclusion in the large-cap Russell 1000 ® Index or the small-cap Russell 2000 ® Index , as well as appropriate growth and value indices.
Russell indices are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. As of the end of June 2024, approximately $10.6 trillion in assets are benchmarked by the U.S. Russell indices, which are owned by FTSE Russell, a global index provider.
Fiona Bassett, CEO of FTSE Russell, an LSEG company, comments:
The Russell indices have continually adapted to the dynamic and evolving US economy, and it is crucial to fully recalibrate the US Russell index suite, ensuring the indices maintain an accurate representation of the market. Moving to a semi-annual reconstitution frequency from 2026 will ensure our indices continue to represent the market and maintain the index’s purpose as a portfolio benchmark.”
For additional information about the Russell 3000 ® Index and the Russell index reconstitution, please visit the “Russell Reconstitution” section of the FTSE Russell website .
About SBC Medical
SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products for cosmetic treatment centers. The company is primarily focused on providing comprehensive management services for franchised clinics, including but not limited to advertising and marketing needs on various platforms (such as social media networks), personnel management (such as recruitment and training), reservations for franchised clinic clients, assistance with rental of housing and facilities for franchised employees, construction and design of franchised clinics, procurement of medical equipment and medical consumables (resale), supply of cosmetic products to franchised clinics for resale to clinic clients, licensing the use of patent-pending and unpatented medical technologies, use of trademarks and registered trademarks, IT software solutions (including but not limited to remote medical consultations), management of franchised clinic customer rewards program (customer loyalty points program), and payment tools for franchised clinics.
For more information, visit https://sbc-holdings.com/
About FTSE Russell, an LSEG company
FTSE Russell is a global index leader, providing innovative benchmarking, analytics and data solutions for investors around the world. It calculates thousands of indices that track and compare markets and asset classes in over 70 countries, covering 98% of the global investable market. Its products and expertise are widely used by institutional and retail investors. Approximately $18.1 trillion is benchmarked against FTSE Russell indices. Major asset owners, managers, ETF providers and investment banks use its indices to assess performance and structure ETFs, structured products and derivatives. The design and management of its indices follows universal principles: a transparent, rules-based methodology informed by independent committees of relevant market participants. FTSE Russell is committed to the highest industry standards in index development and governance, adopting the IOSCO Principles. It also prioritizes continuous innovation and collaborates with clients to expand the range, depth and diversity of its solutions.
